Abstract - Open Access.

Idioma principal

SCNS. 14. Evidence of antidepressant effect of Riparin I, isolated from Aniba riparia, in a model depression chronic in mice

OLIVEIRA, I.C.M.; VASCONCELOS, A.S.; VIDAL, L.M.T.; RODRIGUES, F.A.P.; SOUSA, F.C.F.;

Abstract:

Major Depressant Disorder is one of the most common neuropsychiatric disorders and affects 17-20% of the world population. Despite scientific efforts, its treatment still presents itself with a limited efficacy and a delayed start-up effect. In this context, natural products are a potential source of new drugs. Riparin I (Rip I), one alcamide isolated from Aniba Riparia, has presented promising results. In pre-clinic trials, it has unchained predictive effects of antidepressant and anxiolytic activities in acute behavioral models of depression and anxiety.

Abstract:

Palavras-chave: ,

Palavras-chave:

DOI: 10.5151/isnm-sine19

Referências bibliográficas
Como citar:

OLIVEIRA, I.C.M.; VASCONCELOS, A.S.; VIDAL, L.M.T.; RODRIGUES, F.A.P.; SOUSA, F.C.F.; "SCNS. 14. Evidence of antidepressant effect of Riparin I, isolated from Aniba riparia, in a model depression chronic in mice", p. 24 . In: In I International Symposium in Neuroscience Meeting, 2013 [Blucher Neuroscience Proceedings n.1 v.1]. São Paulo: Blucher, 2014.
ISSN 2357-772x, DOI 10.5151/isnm-sine19

últimos 30 dias | último ano | desde a publicação


downloads


visualizações


indexações